187
Views
3
CrossRef citations to date
0
Altmetric
Review Article

Is CD34 truly a negative marker for mesenchymal stromal cells?

, , &
Pages 1159-1163 | Published online: 15 Oct 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Yu Bai, Yongjun Su, Jinhuo Wang, Na Yao, Lishuang Duan, Tong Liu & Jianrong Guo. (2023) Effects of blood components of preoperative autologous blood donation on functions of myelopoietic stem cells. Hematology 28:1.
Read now
Morgane Couchet, Hui Gao, Felix Klingelhuber, Jutta Jalkanen, Thais De Castro Barbosa, Muhmmad Omar-Hmeadi, Lucas Massier, Natalie Krahmer, Niklas Mejhert & Mikael Rydén. (2023) Adipogenic characterization of immortalized CD55+ progenitor cells from human white adipose tissue. Adipocyte 0:0.
Read now
Athanasios Tampakis, Benjamin Weixler, Silvan Rast, Ekaterini-Christina Tampaki, Eleonora Cremonesi, Venkatesh Kancherla, Nadia Tosti, Christoph Kettelhack, Charlotte K. Y. Ng, Tarik Delko, Savas D. Soysal, Urs von Holzen, Evangelos Felekouras, Nikolaos Nikiteas, Martin Bolli, Luigi Tornillo, Luigi Terracciano, Serenella Eppenberger-Castori, Giulio C. Spagnoli, Salvatore Piscuoglio, Markus von Flüe, Silvio Däster & Raoul A. Droeser. (2021) Nestin and CD34 expression in colorectal cancer predicts improved overall survival. Acta Oncologica 60:6, pages 727-734.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.